Title

Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug.

Document Type

Journal Article

Publication Date

9-13-2018

Journal

Pharmacological research : the official journal of the Italian Pharmacological Society

Volume

136

Inclusive Pages

140-150

DOI

10.1016/j.phrs.2018.09.007

Peer Reviewed

1

Find in your library

Share

COinS